Hepatic Encephalopathy News and Research

RSS
Probiotics effectively prevent hepatic encephalopathy in patients with cirrhosis of the liver

Probiotics effectively prevent hepatic encephalopathy in patients with cirrhosis of the liver

Salix Pharmaceuticals' total net product revenue increases 90% to $384.4 million in Q1 2014

Salix Pharmaceuticals' total net product revenue increases 90% to $384.4 million in Q1 2014

Study shows impact of hepatic encephalopathy on liver disease patients

Study shows impact of hepatic encephalopathy on liver disease patients

New study uses Lumosity games to detect subtle cognitive impairments in patients with cirrhosis

New study uses Lumosity games to detect subtle cognitive impairments in patients with cirrhosis

Phase 2 trial results show GPB reduces hepatic encephalopathy episodes in patients with cirrhosis

Phase 2 trial results show GPB reduces hepatic encephalopathy episodes in patients with cirrhosis

Smartphone app can quickly screen for cognitive dysfunction in patients with cirrhosis

Smartphone app can quickly screen for cognitive dysfunction in patients with cirrhosis

Australia's PBAC recommends use of XIFAXAN 550 mg for hepatic encephalopathy

Australia's PBAC recommends use of XIFAXAN 550 mg for hepatic encephalopathy

Research shows probiotics reduce the development of hepatic encephalopathy

Research shows probiotics reduce the development of hepatic encephalopathy

Friendly bacteria: do we really need to eat probiotic yogurts?

Friendly bacteria: do we really need to eat probiotic yogurts?

KannaLife enters exclusive license with NIH-OTT for patent regarding cannabinoids

KannaLife enters exclusive license with NIH-OTT for patent regarding cannabinoids

Salix first quarter total product revenue increases 62% to $171.1M

Salix first quarter total product revenue increases 62% to $171.1M

Inhibitory control test and lactulose for MHE saves more than $3 million over 5 years

Inhibitory control test and lactulose for MHE saves more than $3 million over 5 years

Rifaximin and lubiprostone offer best options for patients with IBS

Rifaximin and lubiprostone offer best options for patients with IBS

Hyperion acquires worldwide rights to Ucyclyd's Ravicti

Hyperion acquires worldwide rights to Ucyclyd's Ravicti

Induced hyperammonaemia increases daytime sleepiness in patients with cirrhosis

Induced hyperammonaemia increases daytime sleepiness in patients with cirrhosis

N-acetylcysteine plus cortisone shows promise against acute alcoholic hepatitis

N-acetylcysteine plus cortisone shows promise against acute alcoholic hepatitis

Measures to reduce BMI could improve outcome for patients with cirrhosis

Measures to reduce BMI could improve outcome for patients with cirrhosis

Hepatitis C virus (HCV)-associated liver disease after liver transplantation

Hepatitis C virus (HCV)-associated liver disease after liver transplantation

Salix Pharmaceuticals receives three U.S. patents relating to rifaximin

Salix Pharmaceuticals receives three U.S. patents relating to rifaximin

Cognitive impairment may not be fully reversible in patients with liver disease: Study

Cognitive impairment may not be fully reversible in patients with liver disease: Study